Merck & Co., Inc.
MRK.TO (TSX: MRK) TSXAt a glance
- P/E 148.3 — lower than 0% of Healthcare peers (35 companies).
- Market cap $497.72B; average daily dollar volume $550K over the past 3 months — Moderate liquidity.
- No published plan for this ticker.
- 1-year volatility 30.6% (annualized); largest fall from a peak over the past year -12.3%.
Price chart
Split- and dividend-adjusted. All three lines are rebased to 100 at the start of the range, so the chart compares moves, not prices. L marks a LONG plan, S a SHORT plan — each links to that session's day page.
Monthly closes (table version, last 5 years)
| Month | Close |
|---|---|
| 2026-01 | 24.65 |
| 2026-02 | 27.83 |
| 2026-03 | 27.00 |
| 2026-04 | 24.50 |
| 2026-05 | 26.52 |
| 2026-06 | 28.70 |
| 2026-07 | 29.20 |
| 2026-08 | 32.98 |
| 2026-09 | 32.32 |
| 2026-10 | 33.14 |
| 2026-11 | 32.62 |
The Composite is proxied by XIU.TO (iShares S&P/TSX 60 Index ETF); the database holds no Composite index series. The sector fund is a fund, never the index.
Performance
No 1-year performance stored.
| Metric | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
| Stock | +0.3% | +1.0% | +9.3% | +27.6% | — | — | — | — |
| Sector fund (XHC.TO) | +1.5% | +10.9% | +11.1% | +23.8% | +17.3% | +18.8% | +9.1% | +3.4% |
| Composite (XIU.TO, proxy) | +1.8% | +2.8% | -0.1% | +9.4% | +16.1% | +20.0% | +22.0% | +10.5% |
| Difference vs Composite | -1.5% | -1.8% | +9.3% | +18.1% | — | — | — | — |
3Y and 5Y are annualized from 3Y. The Composite is proxied by XIU.TO; the sector fund is iShares Global Healthcare Index ETF (XHC.TO).
Risk and trading
1-year volatility +30.6% (annualized); largest fall from a peak -12.3% (Feb 24, 2026 to Apr 30, 2026); beta 0.76 against the Composite (2Y weekly).
| Volatility (1Y, annualized) | +30.6% |
| Maximum drawdown (1Y) | -12.3% (Feb 24, 2026 to Apr 30, 2026) |
| Beta (2Y weekly, vs Composite) | 0.76 |
| Average daily volume (3M) | 16,829 |
| Dollar volume (3M, average per day) | $550K |
| Liquidity | Moderate (High: $1M or more a day; Moderate: $100K or more; Low: under $100K, by average daily dollar volume.) |
Valuation
P/E 148.3 — lower than 0% of Healthcare peers (35 companies). The sector median P/E is 23.8.
| Multiple | Value | Against sector peers |
|---|---|---|
| P/E (TTM) | 148.3 | Lower than 0% of peers (35 companies; median 23.8) |
| Earnings yield | 0.67% | — |
| P/B | 10.21 | Lower than 10% of peers (39 companies; median 2.09) |
| P/S | Not available: Not available — needs TTM revenue; see financials. | — |
| EV/EBITDA | Not available: Not stored | — |
| Dividend yield | Not available: Not stored | — |
| Payout ratio | Not available: Not available — no stored dividend history yet. | — |
Each multiple is shown against the sector median of the pages' universe as a percentile: "lower than 25% of peers" means the value sits below 25% of them. Valuation multiples are from the Nov 12, 2026 snapshot, and are always printed with that date.
More: dividend rate and earnings yield
Dividend rate: Not available: No dividend rate in the snapshot. Earnings yield is earnings per share divided by price — the inverse of P/E.
Financials
Revenue $65.01B in 2025 (TTM $66.57B); net income $18.25B; free cash flow $12.36B. Reporting currency: USD.
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $59.28B | $60.12B | $64.17B | $65.01B | $66.57B |
| Gross margin | 70.6% | 73.2% | 76.3% | 74.8% | — |
| Net income | $14.52B | $365.0M | $17.12B | $18.25B | $3.17B |
| Free cash flow | $14.71B | $9.14B | $18.10B | $12.36B | $16.06B |
| Diluted shares | 2,537,833,884 | 2,531,633,273 | 2,527,637,335 | 2,474,626,766 | — |
Revenue by year
Free cash flow by year
| Cash | $14.56B |
| Total debt | $49.34B |
| Debt-to-equity | 0.94 |
| Operating margin (latest snapshot, Nov 12, 2026) | Not available: No operating margin in the snapshot |
Figures as reported in stored financials; reporting currency USD. Operating margin is not stored per year, so the latest snapshot value is shown. TTM covers 2025-09-30, 2025-12-31, 2026-03-31, 2026-06-30.
Dividends and splits
No dividend yield stored. No splits on record.
| Year | Dividend per share |
|---|---|
| Not available: No stored dividend history yet. | |
Trailing yield not available is the stored key-stats snapshot value (as of Nov 12, 2026) — the dividend history itself is not stored yet, so no history table is shown.
| Date | Action | Ratio |
|---|---|---|
| Not available: No splits on record for this ticker. | ||
Next ex-dividend date: Not available: No stored ex-dividend dates for equities. Prices on the chart are split- and dividend-adjusted (no splits on record, so nothing to adjust).
Ownership and dilution
Insiders bought 0 times and sold 0 times in the 90 days to Nov 12, 2026. Shares outstanding fell 2.1% over 1 year.
| Insider buys (90 days) | 0 |
| Insider sell (90 days) | 0 |
| Shares outstanding change (1Y) | -2.1% |
| Shares outstanding change (3Y) | -2.5% |
| Held by insiders | Not available: No holding split in the snapshot |
| Held by institutions | Not available: No holding split in the snapshot |
Counts are by filing date. Holdings are from the key-stats snapshot (as of Nov 12, 2026).
No insider trades stored for this ticker.
Peers
Peers in Healthcare, by market cap: LLY.TO, JNJ.TO, ROG.TO, UNH.TO, NVS.TO, AMGN.TO, TMO.TO, GILD.TO.
| Ticker | Price | 1Y % | Market cap | P/E | EV/EBITDA | Div yield | 1Y vol |
|---|---|---|---|---|---|---|---|
| LLY.TO | 50.95 | — | $1663.74B | 46.7 | — | — | +35.3% |
| JNJ.TO | 36.10 | — | $893.92B | 43.5 | — | — | +21.8% |
| ROG.TO | 31.71 | +43.2% | $507.81B | 23.8 | — | — | +25.2% |
| UNH.TO | 18.47 | — | $474.68B | 23.4 | — | — | +35.9% |
| NVS.TO | 31.95 | +32.0% | $404.32B | 31.0 | — | — | +29.4% |
| AMGN.TO | 34.47 | — | $338.75B | 27.4 | — | — | +30.1% |
| TMO.TO | 24.85 | — | $338.08B | 37.1 | — | — | +31.8% |
| GILD.TO | 33.75 | — | $278.88B | — | — | — | +27.7% |
Each row links to its own page when one exists. Peer 1Y returns and volatility use raw closes; peer splits are unadjusted.
analiti.ca history
No published plans for this ticker.
| Date | Side | Entry | Stop | First exit | Exits | Outcome (full ladder) | First exit | Hold |
|---|---|---|---|---|---|---|---|---|
| Not available: No published plans for this ticker. | ||||||||
The full ladder is the headline method: 40/30/20% at the three exits, the last slice held to stop or end. First exit credits the whole position at the first exit level. Full history: the track record.
Superstock score
No Superstock score published for this ticker. The score is the published Superstock screen score — nothing else.
Sector condition: No sector condition published. Superstock screen.
Key dates
| Next earnings | Not available: No company release or exchange notice in the stored data — stored dates are Yahoo-sourced, so none is shown. |
| Last earnings | Not available: No earnings date stored. |
| Next ex-dividend | Not available: No stored ex-dividend dates for equities. |
The next earnings date is shown only from the company's own release or an exchange notice, with a link. The stored last-earnings date is Yahoo-sourced.
Sources and data notes
| Block | Source | As of |
|---|---|---|
| prices, chart, performance, risk | daily_prices (Yahoo) | Nov 12, 2026 |
| valuation, market cap, ownership | yahoo_key_stats snapshot | Nov 12, 2026 |
| financials | financials (Yahoo) | Jun 30, 2026 |
| plans, resolutions | published entries-*.json + track-record.json | Nov 12, 2026 |
| insiders | insider_trades (SEDI filings) | Nov 12, 2026 |
| splits | Split inventory (interim table) | Nov 5, 2026 |
| sector condition | conditions-2026-11-05.json | Nov 5, 2026 |
| Superstock score | superstock_checks + superstock.json | Nov 12, 2026 |
Not available rules. A field older than its freshness limit shows "not available", never a stale number: prices, 3 trading days; fundamentals, 120 days after the fiscal period end plus 45 days. Valuation multiples are always printed with their snapshot date.
Data file: /data/t/MRK.TO.json · Markdown twin: /t/MRK.TO.md
Facts and published history only. Plans are generated by a quant model.